Table 1.
Clinical characteristics of patients recruited for PCTS generation.
| Patient | Sex | Age | Ethnicity | Primary tumour | Pre-treatment | Tumour Grade | Ki67 (%) | Fibrosis Score | CgA |
|---|---|---|---|---|---|---|---|---|---|
| Pt#015 | M | 81 | Caucasian | Lung | Hydroxycarbamide | G2 | 8 | UA | + |
| Pt#045 | M | 58 | Caucasian | Pancreatic | Ocreotide | G2 | 16.9 | F0 | + |
| Pt#051 | F | 51 | Caucasian | Small bowel | – | G2 | 11 | F0 | + |
| Pt#062 | F | 52 | Caucasian | Pancreatic | Streptozocin/Capecitabine | G1 | 3 | F1-2 | + |
| Pt#077 | M | 70 | Caucasian | Small bowel | Lanreotide | G2 | 3.6 | F0 | + |
| Pt#106 | F | 69 | Caucasian | Small bowel | Lanreotide/Ocreotide | G2 | 4.6 | F0 | + |
CgA, Chromogranin A.